Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "020401."
| Active Ingredient: |
DILTIAZEM HYDROCHLORIDE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
TIAZAC |
| Applicant: |
VALEANT INTL |
| Strength: |
120MG |
| Application Number: |
N020401 |
| Product Number: |
001 |
| Approval Date: |
Sep 11, 1995 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB4 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
DILTIAZEM HYDROCHLORIDE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
TIAZAC |
| Applicant: |
VALEANT INTL |
| Strength: |
180MG |
| Application Number: |
N020401 |
| Product Number: |
002 |
| Approval Date: |
Sep 11, 1995 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB4 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
DILTIAZEM HYDROCHLORIDE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
TIAZAC |
| Applicant: |
VALEANT INTL |
| Strength: |
240MG |
| Application Number: |
N020401 |
| Product Number: |
003 |
| Approval Date: |
Sep 11, 1995 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB4 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
DILTIAZEM HYDROCHLORIDE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
TIAZAC |
| Applicant: |
VALEANT INTL |
| Strength: |
300MG |
| Application Number: |
N020401 |
| Product Number: |
004 |
| Approval Date: |
Sep 11, 1995 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB4 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
DILTIAZEM HYDROCHLORIDE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
TIAZAC |
| Applicant: |
VALEANT INTL |
| Strength: |
360MG |
| Application Number: |
N020401 |
| Product Number: |
005 |
| Approval Date: |
Sep 11, 1995 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB4 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
DILTIAZEM HYDROCHLORIDE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
TIAZAC |
| Applicant: |
VALEANT INTL |
| Strength: |
420MG |
| Application Number: |
N020401 |
| Product Number: |
006 |
| Approval Date: |
Oct 16, 1998 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB4 |
| Patent and Exclusivity Info for this product: |
View |
|
Return to Electronic Orange Book Home Page
|
FDA/Center for Drug Evaluation and Research
|
|
Office of Generic Drugs
|
|
Division of Labeling and Program Support
|
|
Update Frequency: |
|
Orange Book Data - Monthly
|
|
Generic Drug Product Information & Patent Information - Daily
|
|
Orange Book Data Updated Through April, 2013
|
|
Patent and Generic Drug Product Data Last Updated: May 24, 2013
|
-
